Concepedia

Paul J. Emmerson

PJ

Statistics

Publications

31

Citations

2.6K

H-Index

19

Active since

1992

Affiliations

Eli Lilly (United States)(Current)

University of Michigan

University of Manchester

University of Chicago

University of Aberdeen

Paul J. Emmerson is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and opioid analgesics.

Publications per year

1992–2024

31

Publications

31

The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL

Paul J. Emmerson, Feng Wang, Yong Du et al. · Nature Medicine · 2017 · 650 citations

, , +7

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

Francis S. Willard, Jonathan D. Douros, M Gabe et al. · JCI Insight · 2020 · 487 citations · Full text

, , +17

Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.

Paul J. Emmerson, M R Liu, J H Woods et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 230 citations

, , +17

Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.

Paul J. Emmerson, Mary J. Clark, Alfred Mansour et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 180 citations

, , +17

Structural determinants of dual incretin receptor agonism by tirzepatide

Bingfa Sun, Francis S. Willard, Dan Feng et al. · Proceedings of the National Academy of Sciences · 2022 · 114 citations · Full text

, , +17

1–5 of 31